Chronic TGF-β exposure drives stabilized EMT, tumor stemness, and cancer drug resistance with vulnerability to bitopic mTOR inhibition
Yoko Katsuno(The University of Tokyo), Rik Derynck(University of California, San Francisco), Kohei Miyazono(The University of Tokyo), Kevan M. Shokat(Howard Hughes Medical Institute), Ziyang Zhang(University of California, Berkeley), Dominique S. Meyer(Idorsia (Switzerland)), Rosemary J. Akhurst(University of California, San Francisco)
Cited by 229
Related Papers
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
|Nature|2013|2.5k
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
|Nature|2010|1.8k
IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response
|Science|2007|1.4k
The translational landscape of mTOR signalling steers cancer initiation and metastasis
|Nature|2012|1.4k
TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue Physiology
|Cold Spring Harbor Perspectives in Biology|2016|1.3k